/

Macro Radar Buy/Sell Trends Sector Rotation Portfolio Updates Institutions Guru Portfolios Insider Trades Smart Money Form 144 Pre-Sale 13D/13G Ownership 8-K Events Watchlist About Settings Login

/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

PHASEUR

PHASEUR — 13F Holders Deep Dive

Phasebio Pharmaceuticals INC

-$3.9M

Net Activity

Institutions Holding

5

Popularity Rank

#12521

Avg Weight

0.00%

Total Value

$15.6K

Ownership Trend

5 institutions currently hold PHASEUR, with 1 net buyers and 7 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2022)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

7

Net Buying Institutions

1

Key Holders

Key Holders

Top 5 by Value

DAFNA Capital Management LLC

Acadian Asset Management LLC

Hamilton Lane Advisors LLC

IPG Investment Advisors LLC

Top 5 by Conviction

DAFNA Capital Management LLC

Acadian Asset Management LLC

Hamilton Lane Advisors LLC

IPG Investment Advisors LLC

View all 5 holding institutions

Quarterly Activity

Recent Activity

+$6.0

Total Buy Value

$144.0K

Total Sell Value

New buy1

Trim0

Add0

Sold out7

1

Net Buyers

7

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding PHASEBIO PHARMACEUTICALS INC (PHASEUR)?

Major stakeholders currently include DAFNA Capital Management LLC ($9.7K), Acadian Asset Management LLC ($4.0K), Hamilton Lane Advisors LLC ($1.0K). Based on the latest 13F filings, there are a total of 5 tracked investment funds and institutions maintaining positions in PHASEUR.

What is the overall institutional sentiment toward PHASEUR recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.9M, driven by 1 managers accumulating shares while 7 reduced their exposure.

Which institutions have been selling or reducing their PHASEUR positions?

In the latest period, 0 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $144.0K.

Are there any notable investors adding PHASEUR to their portfolios?

Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.0.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter